- Conditions: cUTI; Complicated Urinary Tract Infection; Acute Pyelonephritis
Interventions: Drug: CAZ-AVI; Drug: Doripenem
Sponsors: AstraZeneca; AstraZeneca; Cerexa, Inc.
Not yet recruiting - verified May 2012 - Condition: Urinary Tract Infections
Interventions: Drug: Trimethoprim sulfamethoxazole, amoxicillin-clavulanate, cefixime, or cephalexin; Drug: Placebo
Sponsors: Children's Hospital of Philadelphia; Children's Hospital of Philadelphia; Children's Hospital of Pittsburgh; University of Pennsylvania; Westat; National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified May 2012 - Condition: Complicated Urinary Tract Infection (cUTI) Including Acute Pyelonephritis
Interventions: Drug: CAZ-AVI; Drug: Doripenem; Drug: Either 500 mg of Ciprofloxacin (oral); Drug: or 800 mg/160 mg of sulfamethoxazole/trimethoprim (oral)
Sponsors: AstraZeneca; AstraZeneca; Cerexa, Inc.
Not yet recruiting - verified May 2012 - Condition: Cystic Fibrosis
Interventions: Drug: Inhaled Vancomycin; Drug: Placebo (Sterile Water); Drug: Rifampin; Drug: Trimethoprim/Sulfamethoxazole (TMP/SMX); Drug: Doxycycline; Drug: Mupirocin Nasal Ointment; Drug: 4% chlorhexidine gluconate liquid skin cleanser
Sponsors: Johns Hopkins University; Michael Boyle; Case Western Reserve University; Cystic Fibrosis Foundation
Not yet recruiting - verified May 2012 - Condition: Bacterial Conjunctivitis
Interventions: Drug: Moxifloxacin Ophthalmic Solution, 0.5%; Drug: Ofloxacin Ophthalmic Solution, 0.3%
Sponsors: Alcon Research; Alcon Research
Recruiting - verified May 2012 - Condition: COCAINE-RELATED DISORDERS
Interventions: Drug: d-cycloserine; Drug: sugar pill
Sponsors: Johns Hopkins University; Johns Hopkins University; National Institute on Drug Abuse (NIDA)
Recruiting - verified February 2012 - Conditions: Pneumonia, Bacterial; Community-acquired
Interventions: Drug: Ceftaroline; Drug: Levofloxacin
Sponsors: Michigan State University; Gary E. Stein, Pharm.D.; Forest Laboratories
Recruiting - verified February 2012 - Conditions: Skin and Soft Tissue Abscess; Methicillin-resistant Staphylococcus Aureus (MRSA) Infection
Intervention: Drug: Oral Clindamycin
Sponsors: Children's Memorial Hospital; Children's Memorial Hospital
Recruiting - verified December 2011 - Developing Memory Reconsolidation Blockers as Novel Post-traumatic Stress Disorder (PTSD) TreatmentsCondition: Post-traumatic Stress Disorder
Interventions: Drug: Mifepristone; Drug: Cycloserine; Drug: sugar pill
Sponsors: Massachusetts General Hospital; Roger K. Pitman, MD
Recruiting - verified December 2011 - Condition: Urinary Tract Infection
Intervention: Drug: Nitrofurantoin
Sponsors: Duke University; Duke University
Recruiting - verified October 2011 - Conditions: Urologic Neoplasms; Metastatic Bladder Cancer; Urinary Tract Neoplasms
Interventions: Drug: OGX-427 600 mg; Drug: OGX-427 1000 mg; Drug: Placebo
Sponsors: OncoGenex Technologies; OncoGenex Technologies; OncoGenex Pharmaceuticals; PRA International
Recruiting - verified May 2012 - Condition: Congenital Nasolacrimal Duct Obstruction
Interventions: Drug: Besifloxacin; Drug: polymyxin b/trimethoprim - ophthalmic
Sponsors: University of Medicine and Dentistry New Jersey; University of Medicine and Dentistry New Jersey; Bausch & Lomb, Inc.
Recruiting - verified September 2011 - Condition: Obsessive-Compulsive Disorder
Interventions: Drug: D-Cycloserine; Drug: Placebo
Sponsors: Massachusetts General Hospital; Massachusetts General Hospital; National Institute of Mental Health (NIMH); University of South Florida
Recruiting - verified March 2012 - Condition: Smoking Cessation
Interventions: Drug: D-cycloserine; Drug: Placebo
Sponsors: Massachusetts General Hospital; Massachusetts General Hospital
Recruiting - verified July 2011 - Condition: Obsessive-compulsive Disorder
Interventions: Behavioral: Cognitive-behavioral therapy; Drug: d-cycloserine; Drug: Pill placebo
Sponsors: University of South Florida; University of South Florida; Massachusetts General Hospital
Recruiting - verified March 2012 - Conditions: Bacterial Infection; Leukemia; Musculoskeletal Complications; Neutropenia
Interventions: Drug: levofloxacin; Procedure: standard follow-up care
Sponsors: National Cancer Institute (NCI); Children's Oncology Group; National Cancer Institute (NCI)
Recruiting - verified May 2012 - Conditions: Complicated Urinary Tract Infection; Pyelonephritis
Interventions: Drug: CXA-201; Drug: Levofloxacin
Sponsors: Cubist Pharmaceuticals; Cubist Pharmaceuticals
Recruiting - verified March 2012 - Conditions: Complicated Urinary Tract Infection; Pyelonephritis
Interventions: Drug: CXA-201; Drug: Levofloxacin
Sponsors: Cubist Pharmaceuticals; Cubist Pharmaceuticals
Recruiting - verified March 2012 - Conditions: Cystic Fibrosis; Methicillin-resistant Staphylococcus Aureus
Interventions: Drug: Rifampin; Drug: Trimethoprim/Sulfamethoxazole; Drug: Minocycline; Drug: Mupirocin; Drug: chlorhexidine gluconate oral rinse; Drug: 2% Chlorhexidine solution wipes; Behavioral: Environmental Decontamination
Sponsors: University of North Carolina, Chapel Hill; University of North Carolina, Chapel Hill; CF Therapeutics Development Network Coordinating Center; Seattle Children's Hospital; University of Washington; University of Colorado, Denver; Texas Children's Hospital; University of Alabama at Birmingham; St. Louis Children's Hospital; Cook Children's Medical Center; University of Michigan Health System
Recruiting - verified January 2012 - Condition: Post Traumatic Stress Disorder
Interventions: Drug: DCS (D-Cycloserine ) + Prolonged Imaginal Exposure; Drug: DCS (D-Cycloserine ) + Virtual Reality Exposure; Drug: Placebo + Prolonged Imaginal Exposure; Drug: Placebo (sugar pill) + Virtual Reality Exposure
Sponsors: Weill Medical College of Cornell University; Weill Medical College of Cornell University; Department of Defense; Emory University; University of Southern California; VA Long Beach Healthcare System; National Intrepid Center of Excellence (NICoE)
Recruiting - verified March 2012 - Condition: Transplantation Infection
Interventions: Drug: Cidofovir; Other: No Cidofovir
Sponsors: M.D. Anderson Cancer Center; M.D. Anderson Cancer Center
Recruiting - verified March 2012 - Condition: Bladder Cancer
Intervention: Drug: Everolimus and Intravesical Gemcitabine
Sponsors: Memorial Sloan-Kettering Cancer Center; Memorial Sloan-Kettering Cancer Center; Novartis Pharmaceuticals
Recruiting - verified March 2012 - Condition: Urinary Tract Infection
Interventions: Other: Sweetened, dried cranberries; Other: Strawberry Fruit Pieces; Other: Sweetened, dried cranberries; Other: Sweetened, dried cranberries; Other: Strawberry Fruit Pieces; Other: No treatment
Sponsors: University of Wisconsin, Madison; University of Wisconsin, Madison; Ocean Spray Cranberries, Inc.
Recruiting - verified November 2011 - Conditions: Overactive Detrusor; Neurogenic Bladder
Intervention: Drug: Oxybutynin
Sponsors: Watson Pharmaceuticals; Watson Pharmaceuticals
Recruiting - verified February 2012 - Conditions: Obesity; Pharmacokinetics; MRSA; Tuberculosis; PCP
Intervention: Drug: Sulfamethoxazole/trimethoprim
Sponsors: Texas Tech University Health Sciences Center; Texas Tech University Health Sciences Center; National Center for Research Resources (NCRR); University of Texas Southwestern Medical Center
Recruiting - verified February 2012 - Conditions: Posttraumatic Stress Disorder; PTSD
Interventions: Drug: D-cycloserine; Drug: Placebo pill
Sponsors: Tulane University School of Medicine; Tulane University School of Medicine; National Alliance for Research on Schizophrenia and Depression
Recruiting - verified July 2010 - Conditions: Posttraumatic Stress Disorders; PTSD
Interventions: Drug: D-cycloserine; Drug: Placebo pill
Sponsors: Tulane University School of Medicine; Tulane University School of Medicine; National Institute of Mental Health (NIMH)
Recruiting - verified July 2010 - Condition: Catheter-Associated Urinary Tract Infection
Interventions: Drug: Bactrim; Other: Placebo
Sponsors: The Cleveland Clinic; The Cleveland Clinic; American Urogynecologic Society
Recruiting - verified February 2012 - Condition: Complicated Urinary Tract Infections or Pyelonephritis
Interventions: Drug: doripenem; Drug: doripenem placebo; Drug: cefepime; Drug: cefepime placebo
Sponsors: Janssen Research & Development, LLC; Janssen Research & Development, LLC
Recruiting - verified May 2012 - Condition: Phobic Disorders
Interventions: Behavioral: Individual Cognitive Behavioral Therapy (CBT); Drug: D-Cycloserine; Drug: Placebo
Sponsors: Southern Methodist University; Southern Methodist University
Recruiting - verified July 2011 - Conditions: Autistic Disorder; Asperger's Disorder; Pervasive Developmental Disorder NOS
Interventions: Drug: D-cycloserine; Drug: Placebo
Sponsors: Indiana University; Indiana University; Department of Defense
Recruiting - verified April 2012 - Condition: Drug Dependence
Intervention: Drug: 2-4 of the drugs listed below
Sponsors: University of Arkansas; University of Arkansas; National Institute on Drug Abuse (NIDA)
Recruiting - verified February 2012 - Condition: Height Phobia
Interventions: Behavioral: In Vivo Exposure Therapy; Behavioral: Virtual Reality Exposure Therapy; Drug: D-Cycloserine; Drug: Placebo
Sponsors: CAMC Health System; CAMC Health System; West Virginia University; University of Charleston
Recruiting - verified March 2012 - Condition: BK Viremia
Interventions: Drug: levofloxacin; Drug: placebo
Sponsors: Brigham and Women's Hospital; Brigham and Women's Hospital
Recruiting - verified May 2012 - Conditions: Bladder Cancer; Prostate Cancer; Transitional Cell Cancer of the Renal Pelvis and Ureter; Urethral Cancer
Interventions: Biological: bevacizumab; Drug: cisplatin; Drug: gemcitabine hydrochloride; Drug: placebo administration
Sponsors: National Cancer Institute (NCI); Cancer and Leukemia Group B; National Cancer Institute (NCI)
Recruiting - verified August 2011 - Condition: Posttraumatic Stress Disorder
Interventions: Drug: DCS; Other: Placebo
Sponsors: Weill Medical College of Cornell University; Weill Medical College of Cornell University
Recruiting - verified December 2011 - Condition: Abscess
Interventions: Drug: Trimethoprim-sulfamethoxazole; Drug: Sugar pill
Sponsors: Children's Mercy Hospital Kansas City; Children's Mercy Hospital Kansas City; Blue Cross Blue Shield
Recruiting - verified June 2011 - Condition: Body Dysmorphic Disorder
Intervention: Drug: d-cycloserine
Sponsors: Massachusetts General Hospital; Massachusetts General Hospital
Recruiting - verified January 2012 - Condition: Cocaine Use Disorders
Intervention: Drug: cycloserine
Sponsors: Medical University of South Carolina; Medical University of South Carolina; National Institute on Drug Abuse (NIDA)
Recruiting - verified June 2011 - Conditions: Spinal Cord Injury; Neurogenic Bladder; Urinary Tract Infection
Interventions: Other: Shortened course of antibiotic therapy; Other: Standard Therapy
Sponsors: Department of Veterans Affairs; Department of Veterans Affairs
Recruiting - verified April 2012 - Condition: Methicillin-Resistant S.Aureus
Interventions: Drug: Cephalexin; Drug: Placebo; Drug: Trimethoprim-sulfamethoxazole (TS); Drug: Clindamycin
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified January 2012 - Condition: Methicillin-Resistant S.Aureus
Interventions: Drug: Clindamycin; Drug: Placebo; Drug: Trimethoprim-sulfamethoxazole (TS)
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified October 2011 - Condition: Posttraumatic Stress Disorder
Interventions: Drug: D-Cycloserine; Other: placebo
Sponsors: Weill Medical College of Cornell University; Weill Medical College of Cornell University
Recruiting - verified December 2011 - Conditions: Kidney Transplant; Kidney Transplantation; Renal Transplant
Interventions: Drug: ramipril; Drug: ramipril
Sponsors: Pfizer; Pfizer
Recruiting - verified April 2012 - Conditions: Vesico-Ureteral Reflux; Urinary Tract Infections
Interventions: Drug: Trimethoprim-Sulfamethoxazole; Drug: Placebo
Sponsors: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - verified March 2012 - Conditions: Phobic Disorders; Anxiety; Social Phobia
Intervention: Drug: D-Cycloserine
Sponsors: National Institutes of Health Clinical Center (CC); National Institute of Mental Health (NIMH)
Recruiting - verified December 2011 - Conditions: Low Back Pain; Pain
Interventions: Drug: D-cycloserine; Drug: placebo
Sponsors: Northwestern University; Thomas J. Schnitzer
Not yet recruiting - verified January 2012
 |
Anti Infective Agents Urinary Clinical Trials |
